A class action by Viagra users who claimed they had been overcharged for the erectile dysfunction drug has lost steam.
It all started when a generic brand sued Pfizer, the company that makes Viagra, over the validity of a patent.
Their legal battle lasted six years, and the court eventually ruled in favour of the generic company.
After that ruling, a group of consumers took Pfizer to court saying they could have been buying cheaper generic drugs instead of Pfizer’s Viagra for the past six years.
The B.C. Court of Appeal dismissed their class action, saying consumers can’t make these kind of claims under the current patent regime.